Logo via Cigna

Cigna Helps Accelerate Research for a COVID-19 Treatment by Donating Medications

Originally published on Cigna.com 

Cigna Helps Accelerate Research for a COVID-19 Treatment by Donating Medications to Washington University School of Medicine’s Clinical Trial

  • Research to evaluate whether combination treatments of antimalarial drugs and antibiotics decrease respiratory symptoms for COVID-19 patients

To accelerate research for a COVID-19 treatment, Cigna is providing medications to Washington University School of Medicine in St. Louis to initiate a clinical trial that will evaluate antimalarial and antibiotic treatments for COVID-19. The researchers plan to enroll 500 patients, over the course of the study, hospitalized with the novel coronavirus at Barnes – Jewish Hospital in St. Louis, MO.

“Finding a proven treatment for COVID-19 is the most pressing global public health priority,” said Dr. Steve Miller, MD, Chief Clinical Officer, Cigna. “Through our close collaboration with Washington University, we can help fast-track this effort.”

The Food and Drug Administration (FDA) recently granted emergency approval for hospitals to use antimalarial drugs chloroquine and hydroxychloroquine for treatment of COVID-19 in hospitalized patients. The Washington University School of Medicine has implemented a pilot trial investigating the use of these medications in combination with the antibiotic azithromycin to identify the most effective combinations and dosages that will decrease the severity and duration of respiratory symptoms and speed recovery for COVID-19 patients.

Chloroquine and hydroxychloroquine are oral prescription drugs approved to treat malaria and other diseases. Anecdotal reports and in vitro trials suggest these drugs might be useful in treating coronaviruses, including SARS-CoV-2, the virus that causes COVID-19, but definitive evidence is needed.

“There have been only a few small studies that have evaluated chloroquine and hydroxychloroquine in patients with COVID-19, and the results are unclear,” said Infectious Disease Specialist, Rachel M. Presti, MD, PhD, an associate professor of medicine at Washington University School of Medicine, who is co-leading the trial. “Our goal is to determine if any of these medications, alone or in combination, decrease the severity or duration of respiratory symptoms associated with COVID-19.”

Preliminary data could be available as early as six weeks.

About Cigna
Cigna Corporation is a global health service company dedicated to improving the health, well-being and peace of mind of those we serve. Cigna delivers choice, predictability, affordability and access to quality care through integrated capabilities and connected, personalized solutions that advance whole person health. All products and services are provided exclusively by or through operating subsidiaries of Cigna Corporation, including Cigna Health and Life Insurance Company, Cigna Life Insurance Company of New York, Connecticut General Life Insurance Company, Express Scripts companies or their affiliates, and Life Insurance Company of North America.

Such products and services include an integrated suite of health services, such as medical, dental, behavioral health, pharmacy, vision, supplemental benefits, and other related products including group life, accident and disability insurance. Cigna maintains sales capability in over 30 countries and jurisdictions, and has more than 170 million customer relationships throughout the world. To learn more about Cigna®, including links to follow us on Facebook or Twitter, visit www.cigna.com.

 

Latest News

Oak Park, Illinois

Illinois Professor Suspended, Charged with Hate Crime After Allegedly Spitting on Black Woman and Using Racial Slur

An Illinois professor has been suspended from his job and charged with a hate crime after he allegedly spat on and racially attacked a Black female driver in a suburban Chicago grocery store parking lot earlier this month. Antonio Planas of NBC News has reported that Alberto Friedmann, a professor…

Joaquin Castro

New Research Shows a Continued Lack of Hispanic and Latinx Representation in Movies, Media and Publishing

In a bit of disheartening news in the midst of Hispanic Heritage Month, a new government study has confirmed that Latinx individuals are vastly under-included and underrepresented in many parts of the media world. Astrid Galvan of the Associated Press reported on the study from the U.S. Government Accountability Office,…

Newberg, Oregon

Oregon School Employee Suspended for Showing Up to Work in Blackface To Protest State Vaccination Policies

Racial controversies continue to mount at the Newberg Public School system located in the suburbs of Portland, Oregon. Last week, students in the district’s high school conducted a mock “slave auction” on social media in which they ridiculed fellow classmates and discussed how much they would or wouldn’t pay to…